DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Butaclamol
Butaclamol
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Appendix 13C: Clinical Evidence Study Characteristics Tables
Characterization of Binding Sites for H-Spiroperidol in Human Retina
(C) Hit Agreement Between Seeding Densities
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
US8074644.Pdf
Binding Assays (Schizophrenia/Haloperidol/Caudate Nucleus/Neuroleptics/Butaclamol) P
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Tardive Dyskinesia
Fluphenazine Decanoate (Depot) and Enanthate for Schizophrenia (Review)
WO 2013/067519 A2 10 May 2013 (10.05.2013) P O P C T
Molecular Cloning, Characterization, and Localization of a High
(12) Patent Application Publication (10) Pub. No.: US 2009/0076019 A1 Tyers Et Al
Dopamine Receptor Antagonists As New Mode-Of-Action Insecticide Leads for Control of Aedes and Culex Mosquito Vectors
Dopamine Receptors in Human and Calf Brains, Using [3H]Apomorphine and an Antipsychotic Drug (Schizophrenia/Neuroleptics/Caudate Nucleus/Haloperidol/Butaclamol) P
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmaceuticals Appendix
Prototypical Antipsychotic Drugs Protect Hippocampal Neuronal
Top View
Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Case Studies
Dopamine Receptor Binding in the Corpus Striatum of Mammalian Brain (Phenothiazine/Butyrophenone/Catecholamine/Schizophrenia/Adenylate Cyclase) DAVID R
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
Antipsychotic Drugs Which Elicit Little Or No Parkinsonism Bind More Loosely
IBZM: a Potential CNS D-2 Dopamine Receptor Imaging Agent
United States Patent (19) 11 Patent Number: 5,955,459 Bradley Et Al
Human Neurogenesis Assay: Ramelteon
Sigma Receptor-Mediated Alterations in Cellular Morphology and Viability
Mosser Et Al Figs 190702
Dopamine Receptors
Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors Or Are Selective for D 4 Receptors
Pharmaceutical Appendix to the Tariff Schedule 2
Sleep Apnea and CMV Driver Safety
Expression and Characterization of a Dopamine D4R Variant Associated with Delusional Disorder
Genetic and Pharmacological Analysis Controlling Egg Laying In
Parkinson's Disease Quality Measurement Set Update
Pharmaceutical Appendix to the Tariff Schedule 2
Jpet.114.219717.Full.Pdf
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
New Inhibitor of Serotonin and Norepinephrine Uptake David T
A Study of the Discriminative Stimulus Properties and Some Analgesic Properties of the Narcotic Agonist- Antagonist Cyclazocine
Effect of Neuroleptics and Other Drugs on Monoamine Uptake by Membranes of Adrenal Chromaffin Granules A
Heterocyclic Tetracyclic Tetrahydrofuran
Guanidine: a Selective Ligand That Labels Cr-Type
Effects of Long-Term Haloperidol Treatment on the Responsiveness
SKF 10047 and [3H]Haloperidol Binding In